Selective opioid receptor alkylating agents
AssigneeRegents of the University of Minnesota
InventorPhilip S. Portoghese
Life of this patent
Estimating the term…
Abstract
A selective opioid receptor, site-directed alkylating agent useful as a narcotic antagonist and non-addictive analgesic having the formula: ##STR1## wherein R is a Michael acceptor, a haloacetamide or isothiocyanate and R' is cyclopropylmethyl, allyl or substituted allyl. The Michael acceptors may be acrylamides or esters: ##STR2## wherein R.sup.2 is alkyl or aralkyl, and salts thereof. The preparation of the compounds is described, along with experiments involving the use of the compounds.
Claims4
A selective opioid receptor alkylating agent having the formula:
- ##STR15## wherein R is an ester having the general formula:
- ##STR16## wherein R.sup.2 is (CH.sub.2).sub.n H or (CH.sub.2).sub.n Ar and n is 1 to 5, wherein Ar is phenyl, furane, naphthyl, thiophene or substituted phenyl, the substituent being halogen, hydroxy, nitro, methoxy, methyl, trifluoromethyl or amino, and R' is selected from the group consisting of cyclopropylmethyl, allyl and substituted allyl, the substituent being methyl, ethyl, propyl or halogen, and pharmaceutically acceptable salts thereof.
A selective opioid receptor alkylating agent having the formula:
- ##STR17## wherein R is isothiocyanate, and R' is selected from the group consisting of cyclopropylmethyl, allyl and substituted allyl, the substituent being methyl, ethyl, propyl or halogen, and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.